Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ibrahim (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands), A. Neerincx (Amsterdam, Netherlands), J. Riley (Stockley Park, United Kingdom), S. Bates (Stockley Park, United Kingdom), S. Hashimoto (Amsterdam, Netherlands), K. Chung (London, United Kingdom), R. Djukanovic (Southampton, United Kingdom), S. Dahlén (Stockholm, Sweden), I. Adcock (London, United Kingdom), P. Howarth (Southampton, United Kingdom), P. Sterk (Amsterdam, Netherlands), A. Kraneveld (Utrecht, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands). Late Breaking Abstract - Microbiome-driven clusters in severe asthma derived from induced sputum: identification and stability over time.. 1622

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED). Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - Lack of stability of blood eosinophil counts in patients with COPD. Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Management of COVID-19 pneumonia in an enhanced respiratory step down unit: a novel approach. Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Late Breaking Abstract - ENose based phenotyping of newly presented patients with asthma or COPD Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Late Breaking Abstract - Correlation of sputum microRNA-144 expression levels with treatment response among pulmonary tuberculosis patients Source: International Congress 2018 – New developments in tuberculosis Year: 2018 Late Breaking Abstract: Combining lung function and clinical severity score at two increases the predictability of current asthma at ten years Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010 Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations Source: International Congress 2019 – Airway physiology Year: 2019 Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Late Breaking Abstract - Resistomics of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of antimicrobial-resistance-encoding genes Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Late Breaking Abstract - Exacerbation of asthma in childhood: seasonal pattern and risk factors. Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017 Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Late Breaking Abstract - Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 Late Breaking Abstract - Corticosteroid optimisation in severe asthma using composite biomarkers to adjust dose versus a symptom/risk-based algorithm Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma. Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract: Persistent effect of bronchial thermoplasty (BT) in severe asthma at two years Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Late Breaking Abstract - Effect of inhaled corticosteroids on exacerbation of asthma–COPD overlap according to different diagnostic criteria Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019 Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017 Late Breaking Abstract - 12-month lung clinical and functional consequences in patients with severe COVID-19 Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018